查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842403

全球基因治療培養基市場：市場規模、佔有率和趨勢分析（按產品、載體類型、最終用途和地區分類），細分市場預測（2026-2033 年）

Gene Therapy Media Market Size, Share & Trends Analysis Report By Product (Specialty Media, Serum-free Media), By Vector Type (AAV, LV), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基因治療媒體市場摘要

全球基因治療培養基市場預計到 2025 年將價值 4.612 億美元，預計到 2033 年將達到 16.138 億美元，2026 年至 2033 年的複合年成長率為 17.1%。

這一成長是由基因治療研究投入的增加、遺傳性和慢性疾病的日益普遍以及細胞和基因療法研發管線的不斷擴大所推動的。

生物製藥公司與研究機構之間的策略聯盟，以及對創新治療方法的有利監管支持，進一步支撐了市場的積極前景。

罕見遺傳疾病療法的成長和監管支持

基因治療培養基產業的主要驅動力之一是人們日益關注罕見疾病和孤兒遺傳疾病的治療方法研發。全球數百萬人患有超過7000種罕見疾病，其中大多數疾病仍缺乏有效的治療方法。針對脊髓性肌肉萎縮症、血友病和遺傳性視網膜疾病等疾病的臨床試驗數量不斷增加，使得高品質、穩定性強且擴充性的基因治療培養基成為支持研究和商業化生產的重要工具。

同時，美國FDA和歐洲藥品管理局（EMA）等監管機構正在提供加速核准途徑、孤兒藥認定和獎勵，以促進罕見疾病治療領域的創新。這些支持性的法律規範正在縮短產品上市時間，並增加基因治療生態系統內的投資和合作。隨著更多治療方法核准並進入市場，對符合GMP標準的穩定培養基配方的需求預計將會成長，這使得基因治療培養基成為推進罕見遺傳疾病治療的關鍵組成部分。

提高病毒載體生產能力

病毒載體產能的提升是基因治療培養基市場的主要驅動力。隨著基因治療計畫的增加，製造商正大力投資建造大型生產設施，以滿足對腺結合病毒（AAV）、慢病毒和逆轉錄病毒等病毒載體日益成長的需求。這些載體需要高度專業化和最佳化的細胞培養基，以確保高產量、穩定性和安全性。

從小規模實驗室生產過渡到商業化生產，需要能夠支持細胞旺盛生長、高轉染效率和穩定病毒滴度的培養基配方。隨著越來越多的基因療法從臨床試驗走向商業化，對可擴展的、符合GMP規範的病毒載體生產平台及其配套專用培養基的需求預計將大幅成長。這將直接推動基因治療培養基市場的成長。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場關聯性展望
    • 母市場展望
    • 附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素的影響分析
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析

第4章 按產品進行業務分析

  • 產品儀錶板
  • 全球基因治療培養基市場：按產品分類的差異分析
  • 全球基因治療培養基市場規模及產品趨勢分析（2021-2033）
  • 特殊培養基
    • 全球特種介質市場估計值與預測（2021-2033）
  • 無血清培養基
    • 全球無血清培養基市場估計值及預測（2021-2033）
  • 古典媒介
    • 全球古典文化媒體市場估計值與預測（2021-2033）
  • 其他
    • 全球其他培養基市場估計值與預測（2021-2033）

第5章 依向量類型進行商業分析

  • 向量類型儀表板
  • 全球基因治療培養基市場：依載體類型分類的變異分析
  • 全球基因治療培養基市場規模及趨勢分析（按載體類型分類）（2021-2033 年）
  • AAV製作
    • 全球AAV生產市場估計值與預測（2021-2033年）
  • LV 生產
    • 全球低壓電氣生產市場估計值與預測（2021-2033）

第6章 依最終用途進行業務分析

  • 終端用戶儀錶板
  • 全球基因治療培養基市場：依最終用途分類的差異分析
  • 全球基因治療培養基市場規模及趨勢分析（依最終用途分類）（2021-2033 年）
  • 製藥和生物技術公司
    • 全球醫藥與生技市場估計值與預測（2021-2033）
  • CDMO/CRO
    • 全球CDMO/CRO市場估計值與預測（2021-2033年）
  • 研究和學術機構
    • 全球研究和學術機構市場估計值和預測（2021-2033）

7. 基因治療培養基市場：區域估算和趨勢分析（按產品、載體類型和最終用途分類）

  • 區域儀錶板
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 北美基因治療媒體市場（2021-2033）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲基因治療媒體市場（2021-2033）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區基因治療媒體市場（2021-2033）
    • 日本
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲基因治療媒體市場（2021-2033）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲基因治療媒體市場（2021-2033）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析（2025 年）
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Sartorius AG
    • Lonza
    • Danaher Corporation（Cytiva）
    • FUJIFILM Holdings Corporation
    • MP Biomedicals
    • Corning Incorporated
    • PAN-Biotech
    • Bio-Techne（R&D Systems, Inc.）
    • InVitria Inc
    • Florabio AS
    • Revvity
    • Virica
Product Code: GVR-4-68040-753-3

Gene Therapy Media Market Summary

The global gene therapy media market size was estimated at USD 461.2 million in 2025 and is projected to reach USD 1,613.8 million by 2033, growing at a CAGR of 17.1% from 2026 to 2033. This growth is driven by increasing investments in gene therapy research, the rising prevalence of genetic disorders and chronic diseases, and the expanding pipeline of cell and gene-based therapies.

Strategic collaborations between biopharmaceutical companies and research institutions and favorable regulatory support for innovative therapies further contribute to the strong market outlook.

Growth in Rare Genetic Disease Therapies & Regulatory Support

One of the main factors propelling the gene therapy media industry is the growing emphasis on creating treatments for uncommon and orphan genetic illnesses. Millions of people worldwide suffer from more than 7,000 rare diseases, the majority of which do not yet have adequate therapies. The rising number of clinical trials targeting conditions such as spinal muscular atrophy, hemophilia, and inherited retinal disorders creates substantial demand for high-quality, consistent, scalable gene therapy media to support research and commercial manufacturing.

At the same time, regulatory agencies such as the U.S. FDA and the European Medicines Agency (EMA) are providing accelerated pathways, orphan drug designations, and incentives to encourage innovation in rare disease therapies. This supportive regulatory framework reduces time-to-market and increases investment and partnerships across the gene therapy ecosystem. The demand for robust, GMP-compliant media formulations is expected to rise as more therapies gain approval and enter the market, positioning gene therapy media as a vital component in advancing treatments for rare genetic diseases.

Increasing Capacity for Viral Vector Production

The expansion of viral vector production capabilities is a key driver of the gene therapy media market. As the number of gene therapy programs grows, manufacturers invest heavily in large-scale production facilities to meet the increasing demand for viral vectors, such as adeno-associated virus (AAV), lentivirus, and retrovirus. These vectors require highly specialized and optimized cell culture media to ensure high yield, consistency, and safety.

The shift from small-scale laboratory production to commercial-scale manufacturing necessitates media formulations that support robust cell growth, high transfection efficiency, and stable viral titers. The need for scalable, GMP-compliant viral vector production platforms and the specialized media that support them is anticipated to increase dramatically as more gene therapies move from clinical trials to commercialization. This is expected to directly contribute to the growth of the gene therapy media market.

Global Gene Therapy Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global gene therapy media market based on product, vector type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Specialty Media
  • Serum-free Media
  • Classical Media
  • Others
  • Vector Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AAV Production
  • LV Production
  • Other Vectors
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs) & CROs
  • Research and Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Vector Type
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Growth in rare genetic disease therapies and regulatory support
      • 3.3.1.2. Increasing capacity for viral vector production
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Technical and manufacturing challenges
      • 3.3.2.2. Long development timelines
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Gene Therapy Media Market Product, Movement Analysis
  • 4.3. Global Gene Therapy Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Specialty media
    • 4.4.1. Global specialty media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serum-free Media
    • 4.5.1. Global serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Classical Media
    • 4.6.1. Global classical media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Global other media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Vector Type Business Analysis

  • 5.1. Vector Type Segment Dashboard
  • 5.2. Global Gene Therapy Media Market Vector Type, Movement Analysis
  • 5.3. Global Gene Therapy Media Market Size & Trend Analysis, by Vector Type, 2021 to 2033 (USD Million)
  • 5.4. AAV Production
    • 5.4.1. Global AAV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. LV Production
    • 5.5.1. Global LV production market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Gene Therapy Media Market End User, Movement Analysis
  • 6.3. Global Gene Therapy Media Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical and Biotechnology Companies
    • 6.4.1. Global pharmaceutical and biotechnology companies market estimates and
  • 6.5. Contract Development & Manufacturing Organizations (CDMOs) & CROs
    • 6.5.1. Global contract development & manufacturing organizations (CDMOs) & CROs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Global research and academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Gene Therapy Media Market: Regional Estimates and Trend Analysis, by Product, Vector Type, & End-Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada gene therapy media market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico gene therapy media market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden gene therapy media market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway gene therapy media market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.5. Japan
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Singapore gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand gene therapy media market, 2021 - 2033 (USD Million)
    • 7.5.8. South Korea
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. South Korea gene therapy media market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America gene therapy media market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil gene therapy media market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina gene therapy media market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE gene therapy media market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait gene therapy media market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Sartorius AG
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher Corporation (Cytiva)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. FUJIFILM Holdings Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. MP Biomedicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PAN-Biotech
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Bio-Techne (R&D Systems, Inc.)
      • 8.4.10.1. Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives
    • 8.4.11. InVitria Inc
      • 8.4.11.1. Overview
      • 8.4.11.2. Product Benchmarking
      • 8.4.11.3. Strategic Initiatives
    • 8.4.12. Florabio AS
      • 8.4.12.1. Overview
      • 8.4.12.2. Product Benchmarking
      • 8.4.12.3. Strategic Initiatives
    • 8.4.13. Revvity
      • 8.4.13.1. Overview
      • 8.4.13.2. Product Benchmarking
      • 8.4.13.3. Strategic Initiatives
    • 8.4.14. Virica
      • 8.4.14.1. Overview
      • 8.4.14.2. Product Benchmarking
      • 8.4.14.3. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. Global Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 5. Global Gene Therapy Media Market, End use, 2021 - 2033 (USD Million)
  • Table 6. Global Gene Therapy Media Market, by Region, 2021 - 2033 (USD Million)
  • Table 7. North America Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 9. North America Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 10. North America Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 11. North America Gene Therapy Media Market, by End user, 2021 - 2033 (USD Million)
  • Table 12. U.S. Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 13. U.S. Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Gene Therapy Media Market, by End user, 2021 - 2033 (USD Million)
  • Table 15. Canada Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 16. Canada Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 17. Canada Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 18. Mexico Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 19. Mexico Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 20. Mexico Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 21. Europe Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 22. Europe Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 23. Europe Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 24. Europe Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 25. Germany Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 26. Germany Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 27. Germany Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 28. UK Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 29. UK Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 30. UK Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 31. France Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 32. France Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 33. France Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 34. Italy Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 35. Italy Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 36. Italy Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 37. Spain Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 38. Spain Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 39. Spain Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 40. Denmark Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 41. Denmark Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 42. Denmark Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 43. Norway Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 44. Norway Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 45. Norway Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 46. Sweden Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 47. Sweden Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 48. Sweden Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 52. Asia Pacific Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 53. China Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 54. China Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 55. China Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 56. Japan Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 57. Japan Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 58. Japan Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 59. India Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 60. India Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 61. India Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 62. South Korea Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 63. South Korea Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 64. South Korea Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 65. Australia Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 66. Australia Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 67. Australia Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 68. Thailand Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 69. Thailand Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 70. Thailand Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 71. Latin America Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 72. Latin America Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 73. Latin America Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 74. Latin America Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 75. Brazil Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 76. Brazil Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 77. Brazil Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 78. Argentina Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 79. Argentina Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 80. Argentina Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 81. Middle East and Africa Gene Therapy Media Market, by Country, 2021 - 2033 (USD Million)
  • Table 82. Middle East and Africa Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 83. Middle East and Africa Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 84. Middle East and Africa Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 85. South Africa Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 86. South Africa Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 87. South Africa Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 90. Saudi Arabia Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 91. UAE Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 92. UAE Gene Therapy Media Market, by Application, 2021 - 2033 (USD Million)
  • Table 93. UAE Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Gene Therapy Media Market, by Product, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Gene Therapy Media Market, by Vector Type, 2021 - 2033 (USD Million)
  • Table 96. Kuwait Gene Therapy Media Market, by End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Gene therapy media market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Gene therapy media market: Product outlook key takeaways
  • Fig. 19 Gene therapy media market: Product movement analysis
  • Fig. 20 Specialty media market, 2021 - 2033 (USD Million)
  • Fig. 21 Serum-free Media market, 2021 - 2033 (USD Million)
  • Fig. 22 Classical media market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Gene therapy media market: Vector type outlook key takeaways
  • Fig. 25 Gene therapy media market: Vector type movement analysis
  • Fig. 26 AAV production market, 2021 - 2033 (USD Million)
  • Fig. 27 LV production market, 2021 - 2033 (USD Million)
  • Fig. 28 Others production market, 2021 - 2033 (USD Million)
  • Fig. 29 Gene therapy media market: End Use outlook key takeaways
  • Fig. 30 Gene therapy media market: End Use movement analysis
  • Fig. 31 Pharmaceutical and biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 32 Contract Development & Manufacturing Organizations (CDMOs) & CROs market, 2021 - 2033 (USD Million)
  • Fig. 33 Research and Academic Institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S. gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Europe gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific gene therapy media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 MEA gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait gene therapy media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Market position analysis